In pharmaceutical development, regulatory documentation is not simply an administrative task. It is a critical step that directly impacts approval timelines. When you are responsible for preparing DMF (Drug Master File) and drug product submissions, every section must be scientifically accurate, internally consistent, and aligned with regulatory expectations. Preparing a complete dossier often takes several months and, in many cases, close […]
If you’re responsible for regulatory renewals, 2026 is not business as usual. Health authorities across the globe are no longer just accepting electronic submissions — they are actively enforcing precision, structure, and lifecycle discipline. When your product licence is on the line, renewal submissions must be more than complete; they must be technically flawless, audit-ready, and digitally optimised from day one. Regulators such as the U.S. FDA, […]
How to Successfully Update Your Dossier: A Guide to Post-Approval Variations So, you’ve got the Marketing Authorisation (MA) for your medicinal product! But, let’s be real, it’s not a one-and-done deal. As your product’s lifecycle progresses, you’ll need to make updates to its dossier to ensure it remains compliant with regulatory requirements. What’s a Variation, Anyway? A variation is any change to a medicinal product’s registered dossier, decision granting MA, Summary of Product Characteristics, Package Leaflet, […]
Pharmaceutical companies planning to market their products internationally must navigate a complex web of regulatory submission requirements. While many regions follow the ICH Common Technical Document (CTD) or its electronic version (eCTD), each regulatory authority has its own specifications, processes, and expectations. Understanding these differences is essential for regulatory affairs professionals to avoid delays, technical […]